開放角緑内障:世界の治験レビュー(2015年上半期版)

◆英語タイトル:Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2711CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年6月11日
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における開放角緑内障 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 開放角緑内障
  - 当レポートの概要
・開放角緑内障:各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015″ provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Open-Angle Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Open-Angle Glaucoma 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Actavis plc 41
Clinical Trial Overview of Actavis plc 41
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Santen Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 48
Aerie Pharmaceuticals, Inc. 51
Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 51
Merck & Co., Inc. 53
Clinical Trial Overview of Merck & Co., Inc. 53
Valeant Pharmaceuticals International, Inc. 54
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 54
QLT Inc. 55
Clinical Trial Overview of QLT Inc. 55
Mati Therapeutics Inc. 56
Clinical Trial Overview of Mati Therapeutics Inc. 56
Kowa Company, Ltd. 57
Clinical Trial Overview of Kowa Company, Ltd. 57
Clinical Trial Overview of Top Institutes / Government 58
Aristotle University Of Thessaloniki 58
Clinical Trial Overview of Aristotle University Of Thessaloniki 58
Medical University of Vienna 59
Clinical Trial Overview of Medical University of Vienna 59
Tehran University of Medical Sciences 60
Clinical Trial Overview of Tehran University of Medical Sciences 60
The University of Tokyo 61
Clinical Trial Overview of The University of Tokyo 61
University of Colorado 62
Clinical Trial Overview of University of Colorado 62
University of Colorado Denver 63
Clinical Trial Overview of University of Colorado Denver 63
Association for Research in Supporting System of Chronic Diseases 64
Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 64
Beijing Tongren Hospital 65
Clinical Trial Overview of Beijing Tongren Hospital 65
Federal University of Sao Paulo 66
Clinical Trial Overview of Federal University of Sao Paulo 66
Kyoto Prefectural University of Medicine 67
Clinical Trial Overview of Kyoto Prefectural University of Medicine 67
Five Key Clinical Profiles 68
Appendix 95
Abbreviations 95
Definitions 95
Research Methodology 96
Secondary Research 96
About GlobalData 97
Contact Us 97
Disclaimer 97
Source 97

List of Tables
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Open-Angle Glaucoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Open-Angle Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Open-Angle Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 41
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 45
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 48
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 51
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 53
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 54
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 55
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 56
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 57
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 58
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 59
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 60
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 61
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 62
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 63
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015* 64
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Tongren Hospital, 2015* 65
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 66
Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 67

List of Figures
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 96

【掲載企業】

Novartis AG
Actavis plc
Pfizer Inc.
Santen Pharmaceutical Co., Ltd.
Aerie Pharmaceuticals, Inc.
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
QLT Inc.
Mati Therapeutics Inc.
Kowa Company, Ltd.

【レポートのキーワード】

開放角緑内障、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 開放角緑内障:世界の治験レビュー(2015年上半期版)(Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆